FDA Approved: DULOXETINE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental abbreviated new drug application for duloxetine hydrochloride from Aurobindo Pharma Limited (ANDA 090778), enabling a generic ve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy
• Fibromyalgia
• Generalized Anxiety Disorder
• Major Depressive Disorder

Drugs mentioned

• Duloxetine hydrochloride (duloxetine)

Snippet

SUPPL AP for DULOXETINE (DULOXETINE HYDROCHLORIDE)